| 摘要 |
FIELD: medicine, pharmaceutics.SUBSTANCE: described is a novel crystalline salt of sitagliptin - sitagliptin malate and containing it pharmaceutical composition; the described salt is dipeptidylpeptidase-IV inhibitor and can be applied in medicine in treatment of type 2 diabetes mellitus.EFFECT: invention can be applied in medicine in treatment of type 2 diabetes mellitus.2 cl, 17 ex, 29 tbl, 18 dwg |
